Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAVEXO: Fluid Expansion Strategies in Shock
NCT02645851Terminated
- Sponsor
- Centre Hospitalier Régional d'Orléans
- Start
- Jan 2016
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in Shock and hypovolemia (3 arms), sponsored by Centre Hospitalier Régional d'Orléans. Primary endpoint: PaO2/FiO2 ratio changes at 24 hours. Started Jan 2016; status: terminated.
02
Conditions
Shockhypovolemia
Beyond the preview
Go deeper on NCT02645851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02645851.